These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23681309)

  • 1. The anticancer activity of alpha-tomatine against mammary adenocarcinoma in mice.
    Tomsik P; Micuda S; Sucha L; Cermakova E; Suba P; Zivny P; Mazurova Y; Knizek J; Niang M; Rezacova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Jun; 157(2):153-61. PubMed ID: 23681309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination.
    Granda TG; Filipski E; D'Attino RM; Vrignaud P; Anjo A; Bissery MC; Lévi F
    Cancer Res; 2001 Mar; 61(5):1996-2001. PubMed ID: 11280758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy inhibits development and progression of mammary tumours in immunocompetent mice.
    Ottewell PD; Brown HK; Jones M; Rogers TL; Cross SS; Brown NJ; Coleman RE; Holen I
    Breast Cancer Res Treat; 2012 Jun; 133(2):523-36. PubMed ID: 21956211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
    Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH
    Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway.
    El-Ashmawy NE; Khedr NF; El-Bahrawy HA; Abo Mansour HE
    Tumour Biol; 2017 May; 39(5):1010428317692235. PubMed ID: 28459206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of doxorubicin niosomes against an ovarian cancer cell line and three in vivo mouse tumour models.
    Uchegbu IF; Double JA; Kelland LR; Turton JA; Florence AT
    J Drug Target; 1996; 3(5):399-409. PubMed ID: 8866659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginger extract adjuvant to doxorubicin in mammary carcinoma: study of some molecular mechanisms.
    El-Ashmawy NE; Khedr NF; El-Bahrawy HA; Abo Mansour HE
    Eur J Nutr; 2018 Apr; 57(3):981-989. PubMed ID: 28229277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
    Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
    Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antitumoral effect of combination E gene therapy and Doxorubicin in MCF-7 breast cancer cells.
    Rama AR; Prados J; Melguizo C; Burgos M; Alvarez PJ; Rodriguez-Serrano F; Ramos JL; Aranega A
    Biomed Pharmacother; 2011 Jul; 65(4):260-70. PubMed ID: 21723082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer.
    Nishikawa K; Asai T; Shigematsu H; Shimizu K; Kato H; Asano Y; Takashima S; Mekada E; Oku N; Minamino T
    J Control Release; 2012 Jun; 160(2):274-80. PubMed ID: 22020380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice.
    Mizuno Y; Naoi T; Nishikawa M; Rattanakiat S; Hamaguchi N; Hashida M; Takakura Y
    J Control Release; 2010 Jan; 141(2):252-9. PubMed ID: 19778560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroporation adopting trains of biphasic pulses enhances in vitro and in vivo the cytotoxic effect of doxorubicin on multidrug resistant colon adenocarcinoma cells (LoVo).
    Meschini S; Condello M; Lista P; Vincenzi B; Baldi A; Citro G; Arancia G; Spugnini EP
    Eur J Cancer; 2012 Sep; 48(14):2236-43. PubMed ID: 22240284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytotoxic effect of α-tomatine in MCF-7 human adenocarcinoma breast cancer cells depends on its interaction with cholesterol in incubation media and does not involve apoptosis induction.
    Sucha L; Hroch M; Rezacova M; Rudolf E; Havelek R; Sispera L; Cmielova J; Kohlerova R; Bezrouk A; Tomsik P
    Oncol Rep; 2013 Dec; 30(6):2593-602. PubMed ID: 24100733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boldine Inhibits Mouse Mammary Carcinoma In Vivo and Human MCF-7 Breast Cancer Cells In Vitro.
    Tomšík P; Mičuda S; Muthná D; Čermáková E; Havelek R; Rudolf E; Hroch M; Kadová Z; Řezáčová M; Ćmielová J; Živný P
    Planta Med; 2016 Nov; 82(16):1416-1424. PubMed ID: 27611982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and pharmacological effects of mitoxantrone and acetyl-L-carnitine in mice with a solid form of Ehrlich tumour.
    Niang M; Soukup T; Zivný P; Tomšík P; Bukač J; Rezáčová M; Stoklasová A; Cerman J; Sišpera L
    Chemotherapy; 2011; 57(1):35-42. PubMed ID: 21212670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin.
    Cheung RY; Rauth AM; Ronaldson PT; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2006 Apr; 62(3):321-31. PubMed ID: 16330194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-, peri-, and postoperative chemotherapy for breast cancer: is one better than the other?
    Murthy MS; Scanlon EF; Reid SE; Yang XF
    J Surg Oncol; 1996 Apr; 61(4):273-7. PubMed ID: 8627997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 breast adenocarcinoma cells invasion/migration by α-tomatine through activating PKCα/ERK/NF-κB-dependent MMP-2/MMP-9 expressions.
    Shi MD; Shih YW; Lee YS; Cheng YF; Tsai LY
    Cell Biochem Biophys; 2013 May; 66(1):161-74. PubMed ID: 23114726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.